DNA-dependent protein kinase (DNA-PK) phosphorylates and activates TonEBP/NFAT5 in response to hypertonicity

被引：0
|
作者：
Lee, SD
Colla, E
Park, WK
Chen, DJ
Kwon, HM
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A482 / A482
页数：1
相关论文
共 50 条
  • [41] DNA-dependent protein kinase (DNA-PK) as a potential therapeutic target in non-small lung cancer cell lines (NSCLC)
    Sak, A.
    Groneberg, M.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 123 - 123
  • [42] DNA-dependent protein kinase
    Jackson, SP
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (07): : 935 - 938
  • [43] The DNA-dependent protein kinase
    Smith, GCM
    Jackson, SP
    GENES & DEVELOPMENT, 1999, 13 (08) : 916 - 934
  • [44] DNA-dependent protein kinase
    Teraoka, H
    Watanabe, F
    SEIKAGAKU, 2000, 72 (01): : 26 - 38
  • [45] A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia
    Bouquet, Fanny
    Ousset, Marielle
    Biard, Denis
    Fallone, Frederique
    Dauvillier, Stephanie
    Frit, Philippe
    Salles, Bernard
    Muller, Catherine
    JOURNAL OF CELL SCIENCE, 2011, 124 (11) : 1943 - 1951
  • [46] Chromium-mediated apoptosis: Involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes
    Hill, Richard
    Leidal, Andrew M.
    Madureira, Patricia A.
    Gillis, Laura D.
    Waisman, David M.
    Chiu, Arthur
    Lee, Patrick W. K.
    DNA REPAIR, 2008, 7 (09) : 1484 - 1499
  • [47] Preclinical characterization of VX-984, a selective DNA-dependent protein kinase (DNA-PK) inhibitor in combination with doxorubicin in breast and ovarian cancers
    Boucher, D.
    Newsome, D.
    Takemoto, D.
    Hillier, S.
    Wang, Y.
    Arimoto, R.
    Maxwell, J.
    Charifson, P.
    Fields, S. Z.
    Tanner, K.
    Penney, M. S.
    CANCER RESEARCH, 2017, 77
  • [48] The DNA-dependent protein kinase (DNA-PK) complex recruits the facilitator of chromatin transcription (FACT) complex and induces the exit of FACT from the nucleolus in response to cisplatin treatment
    Lazaro, Jean-Bernard
    Dejmek, Janna
    Iglehart, James Dirk
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3548S - 3548S
  • [49] Discovery and initial SAR of morpholine-based inhibitors of DNA-dependent protein kinase (DNA-PK) for use as radiosensitizers in cancer treatment.
    Kesicki, EA
    Kaufman, RJ
    Halbrook, J
    Kashishian, A
    Fowler, KW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U13 - U13
  • [50] A multicenter phase I trial of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814 in patients with solid tumors.
    van Bussel, Mark
    Mau-Soerensen, Morten
    Damstrup, Lars
    Nielsen, Dorte
    Verheul, Henk M. W.
    Aftimos, Philippe Georges
    De Jonge, Maja J.
    Berghoff, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345